Recovered COVID-19 patients’ plasma: what is this experimental therapy?
MARCH 30, 2020 11:28:00 AM
The US Food and Drug Administration (FDA) last week approved use of blood plasma from recovered patients to treat severely critical COVID-19 patients.
Cancer Nanotechnology
Hace 8 horas
.png)
No hay comentarios:
Publicar un comentario